GLIMPSE GROUP INC/THE (VRAR) Fundamental Analysis & Valuation

NASDAQ:VRAR • US37892C1062

Current stock price

0.68 USD
+0.02 (+3.03%)
Last:

This VRAR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VRAR Profitability Analysis

1.1 Basic Checks

  • In the past year VRAR has reported negative net income.
  • VRAR had a negative operating cash flow in the past year.
  • In the past 5 years VRAR always reported negative net income.
  • In the past 5 years VRAR always reported negative operating cash flow.
VRAR Yearly Net Income VS EBIT VS OCF VS FCFVRAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • With a Return On Assets value of -14.02%, VRAR is not doing good in the industry: 77.01% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -15.92%, VRAR is doing worse than 63.22% of the companies in the same industry.
Industry RankSector Rank
ROA -14.02%
ROE -15.92%
ROIC N/A
ROA(3y)-57.32%
ROA(5y)-75.33%
ROE(3y)-108.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VRAR Yearly ROA, ROE, ROICVRAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K

1.3 Margins

  • VRAR has a Gross Margin of 65.39%. This is amongst the best in the industry. VRAR outperforms 86.21% of its industry peers.
  • VRAR's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VRAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.58%
GM growth 5Y10.24%
VRAR Yearly Profit, Operating, Gross MarginsVRAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VRAR Health Analysis

2.1 Basic Checks

  • VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VRAR has been increased compared to 1 year ago.
  • Compared to 5 years ago, VRAR has more shares outstanding
  • There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRAR Yearly Shares OutstandingVRAR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
VRAR Yearly Total Debt VS Total AssetsVRAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -0.87, we must say that VRAR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.87, VRAR is doing worse than 77.01% of the companies in the same industry.
  • There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.87
ROIC/WACCN/A
WACC9.29%
VRAR Yearly LT Debt VS Equity VS FCFVRAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 3.34 indicates that VRAR has no problem at all paying its short term obligations.
  • VRAR's Current ratio of 3.34 is amongst the best of the industry. VRAR outperforms 81.61% of its industry peers.
  • VRAR has a Quick Ratio of 3.34. This indicates that VRAR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.34, VRAR belongs to the top of the industry, outperforming 81.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 3.34
VRAR Yearly Current Assets VS Current LiabilitesVRAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VRAR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.61% over the past year.
  • VRAR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.60%.
  • The Revenue has been growing by 40.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)61.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.6%
Revenue growth 3Y13.14%
Revenue growth 5Y40.11%
Sales Q2Q%-42.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 63.88% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 26.79% on average over the next years. This is a very strong growth
EPS Next Y31.43%
EPS Next 2Y63.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.54%
Revenue Next 2Y26.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VRAR Yearly Revenue VS EstimatesVRAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
VRAR Yearly EPS VS EstimatesVRAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. VRAR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VRAR. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 8.33, the valuation of VRAR can be described as reasonable.
  • VRAR's Price/Forward Earnings ratio is rather cheap when compared to the industry. VRAR is cheaper than 88.51% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, VRAR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.33
VRAR Price Earnings VS Forward Price EarningsVRAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRAR Per share dataVRAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • VRAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • VRAR's earnings are expected to grow with 63.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.88%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VRAR Dividend Analysis

5.1 Amount

  • VRAR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VRAR Fundamentals: All Metrics, Ratios and Statistics

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (2/18/2026, 8:06:42 PM)

0.68

+0.02 (+3.03%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners13.21%
Inst Owner Change9.99%
Ins Owners17.06%
Ins Owner Change0.3%
Market Cap14.33M
Revenue(TTM)9.49M
Net Income(TTM)-2.57M
Analysts82.86
Price Target2.67 (292.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.66%
Min Revenue beat(2)-8.58%
Max Revenue beat(2)-4.73%
Revenue beat(4)1
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.58%
Max Revenue beat(4)0.22%
Revenue beat(8)2
Avg Revenue beat(8)0.19%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-60%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-15.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.33
P/S 1.51
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 2.71
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.08
Fwd EY12%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.45
BVpS0.77
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -14.02%
ROE -15.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.39%
FCFM N/A
ROA(3y)-57.32%
ROA(5y)-75.33%
ROE(3y)-108.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.58%
GM growth 5Y10.24%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.8%
Cap/Sales 0.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 3.34
Altman-Z -0.87
F-Score4
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)5.84%
Cap/Depr(5y)30.91%
Cap/Sales(3y)0.63%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y31.43%
EPS Next 2Y63.88%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.6%
Revenue growth 3Y13.14%
Revenue growth 5Y40.11%
Sales Q2Q%-42.63%
Revenue Next Year-6.54%
Revenue Next 2Y26.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.33%
OCF growth 3YN/A
OCF growth 5YN/A

GLIMPSE GROUP INC/THE / VRAR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GLIMPSE GROUP INC/THE (VRAR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VRAR.


Can you provide the valuation status for GLIMPSE GROUP INC/THE?

ChartMill assigns a valuation rating of 4 / 10 to GLIMPSE GROUP INC/THE (VRAR). This can be considered as Fairly Valued.


What is the profitability of VRAR stock?

GLIMPSE GROUP INC/THE (VRAR) has a profitability rating of 1 / 10.


Can you provide the financial health for VRAR stock?

The financial health rating of GLIMPSE GROUP INC/THE (VRAR) is 7 / 10.